Outcomes and prognostic factors in thyroid cancer patients with cranial metastases: A retrospective cohort study of 4,683 patients

被引:12
|
作者
Hong, Yi-Wen [1 ]
Lin, Jen-Der [2 ]
Yu, Ming-Chin [1 ]
Hsu, Chih-Chieh [1 ]
Lin, Yann-Sheng [1 ]
机构
[1] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Branch, Dept Surg, 5 Fuxing St, Taoyuan 333, Taiwan
[2] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Branch, Div Endocrinol & Metab,Dept Internal Med, 5 Fuxing St, Taoyuan 333, Taiwan
关键词
Thyroid cancer; Brain metastasis; Skull metastasis; Radioiodine; Surgery; BRAIN METASTASES; FOLLOW-UP; DISTANT METASTASIS; SKULL METASTASIS; CARCINOMA; PAPILLARY; RADIOIODINE; MANAGEMENT;
D O I
10.1016/j.ijsu.2018.06.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Cranial metastasis of thyroid cancer is rare. The aim of this study was to analyse the clinical characteristics, treatments and outcomes of thyroid cancer patients with cranial metastasis and to identify the associated prognostic factors. Materials and methods: Between January 1977 and August 2017, a total of 4683 patients were histologically confirmed to have thyroid cancer. Among them, 25 patients (0.53%) were identified as having cranial metastases, and their medical records were reviewed. The Kaplan-Meier method with a log-rank test was performed with cancer-specific survival as the main outcome. Cox regression analysis was used to examine the potential prognostic factors influencing patient survival. Results: Of the 25 patients, 21 were female, and 4 were male. The median age at the time of diagnosis of cranial metastasis was 63 years. Sixteen patients had metastases to the brain, and nine patients had metastases involving the skull only. Papillary carcinoma and follicular carcinoma accounted for 84.0% of cases. Twenty-four cases (96.0%) had extracranial metastases at the time of diagnosis of cranial metastases. Twenty patients received surgery, and 4 patients received palliative radiotherapy. One patient received supportive care only. The median cancer-specific survival after the diagnosis of cranial metastases was 27 months. According to the Kaplan-Meier test, 3 factors had a significant impact on survival, the metastatic site, histological types and surgical resection. According to the Cox regression analysis, skull metastases (HR: 0.274, 95% CI: 0.083-0.904, p = 0.033) and surgical resection (HR: 0.134, 95% CI: 0.019-0.929, p = 0.042) were identified as independent prognostic factors for a better outcome. Conclusions: Surgical resection is the mainstay therapy for thyroid cancer patients with cranial metastasis. Cranial metastases involving the skull only are associated with a better outcome.
引用
收藏
页码:182 / 187
页数:6
相关论文
共 50 条
  • [31] Prognostic significance of osteopenia in patients with colorectal cancer: A retrospective cohort study
    Kamada, Teppei
    Furukawa, Kenei
    Takahashi, Junji
    Nakashima, Keigo
    Nakaseko, Yuichi
    Suzuki, Norihiko
    Yoshida, Masashi
    Ohdaira, Hironori
    Ikegami, Toru
    Suzuki, Yutaka
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2021, 5 (06): : 832 - 843
  • [32] Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis
    Naoki Niikura
    Naoki Hayashi
    Norikazu Masuda
    Seiki Takashima
    Rikiya Nakamura
    Ken-ichi Watanabe
    Chizuko Kanbayashi
    Mayumi Ishida
    Yasuo Hozumi
    Michiko Tsuneizumi
    Naoto Kondo
    Yoichi Naito
    Yayoi Honda
    Akira Matsui
    Tomomi Fujisawa
    Risa Oshitanai
    Hiroyuki Yasojima
    Yutaka Tokuda
    Shigehira Saji
    Hiroji Iwata
    Breast Cancer Research and Treatment, 2014, 147 : 103 - 112
  • [33] Treatment outcomes and the associated factors among breast cancer patients in Tanzania: a retrospective cohort study
    Kivuyo, Nashivai E.
    Kitua, Daniel W.
    Chikelea, Martin E.
    Misidai, Mungeni A.
    Mwanga, Ally H.
    Nyongole, Obadia, V
    Akoko, Larry O.
    ECANCERMEDICALSCIENCE, 2025, 19
  • [34] RADIOTHERAPY FOR BRAIN METASTASES FROM THYROID CANCER: A RETROSPECTIVE COHORT STUDY
    Blomain, Erik
    Berta, Scott
    Hug, Nicholas
    Giao, Duc
    Meola, Antonio
    Binkley, Michael
    Shahsavari, Nastaran
    Desai, Kaniksha
    Chang, Steven
    Soltys, Scott
    Pollom, Erqi
    NEURO-ONCOLOGY, 2021, 23 : 42 - 42
  • [35] Survival and prognostic factors of lung cancer patients with preexisting connective tissue disease: a retrospective cohort study
    Yang, Huaxia
    Yao, Zhuoran
    Zhou, Xiaoxiang
    Bing, Zhongxing
    Cao, Lei
    Cao, Zhili
    Li, Shanqing
    Zhang, Xuan
    Zhao, Yan
    Zeng, Xiaofeng
    Zhang, Fengchun
    Liang, Naixin
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (21)
  • [36] Prognostic factors and outcomes in COVID-19 patients requiring prolonged mechanical ventilation: a retrospective cohort study
    Melamed, Roman
    Paz, Francisco
    Jepsen, Stacy
    Smith, Claire
    Saavedra, Ramiro
    Mulder, Maximilian
    Masood, Adnan
    Huelster, Joshua
    Kirkland, Lisa
    Guenther, Alena
    Boland, Lori
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [37] Prognostic factors and outcomes in COVID-19 patients requiring prolonged mechanical ventilation: a retrospective cohort study
    Melamed, Roman
    Paz, Francisco
    Jepsen, Stacy
    Smith, Claire
    Saavedra, Ramiro
    Mulder, Maximilian
    Masood, Adnan
    Huelster, Joshua
    Kirkland, Lisa
    Guenther, Alena
    Boland, Lori
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [38] CLINICAL FEATURES AND PROGNOSTIC OUTCOMES OF YOUNG CANCER PATIENTS: A RETROSPECTIVE STUDY
    Wang, X. -K.
    Wu, Y.
    Zhou, M. -H.
    WORLD CANCER RESEARCH JOURNAL, 2024, 11
  • [39] Obstetric outcomes in thyroid cancer survivors: A retrospective cohort study
    Liu, Dongming
    Wei, Yuan
    Zhao, Yangyu
    Li, Rong
    Yan, Jie
    Qiao, Jie
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2021, 155 (01) : 119 - 124
  • [40] Prognostic Factors for Bone Survival and Functional Outcomes in Patients With Breast Cancer Spine Metastases
    Qiao, Rui-Qi
    Zhang, Hao-Ran
    Ma, Rong-Xing
    Li, Rui-Feng
    Hu, Yong-Cheng
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21